You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3-Iodobenzylguanidine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pheochromocytoma, Neuroblastoma Trial in Princeton (123I-mIBG (meta-iodobenzylguanidine))

Completed
  • Pheochromocytoma
  • Neuroblastoma
  • 123I-mIBG (meta-iodobenzylguanidine)
  • Princeton, New Jersey
    GE Healthcare
May 29, 2019

Lewy Body Disease, Dementia, Parkinsonism Trial in Rochester (meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy)

Enrolling by invitation
  • Lewy Body Disease
  • +4 more
  • meta-iodobenzylguanidine (MIBG) (123I)
  • 123I-MIBG scintigraphy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 23, 2022

Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

Active, not recruiting
Has Results
  • Disseminated Neuroblastoma
  • +5 more
  • Birmingham, Alabama
  • +22 more
Mar 3, 2022

Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

Recruiting
  • Neuroblastoma
  • 131I-MIBG
  • +4 more
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)

Available
  • Neuroblastoma
  • Pheochromocytoma
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 4, 2022

Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Dallas (131 I-Metaiodobenzylguanidine, Potassium Iodide, G-csf)

No longer available
  • Relapsed Neuroblastoma
  • Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine
  • +2 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Apr 13, 2022

Glioma, Childhood Brainstem, Neuroblastoma Trial in San Francisco, Boston (External beam radiotherapy,

Not yet recruiting
  • Glioma, Childhood Brainstem
  • Neuroblastoma
  • External beam radiotherapy
  • 131I-Metaiodobenzylguanidine (MIBG)
  • San Francisco, California
  • +1 more
Aug 17, 2023

Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

Recruiting
  • Neuroblastoma
  • +2 more
  • San Francisco, California
  • +15 more
Jan 7, 2022

Ventricular Tachycardia, Arrhythmia Trial in Baltimore (123I-metaiodobenzylguanidine)

Completed
Has Results
  • Ventricular Tachycardia
  • Arrhythmia
  • Baltimore, Maryland
    University of Maryland Medical Center, EP Lab, Rm. N3W77
Jan 25, 2022

Metastatic Neuroblastoma Trial in London, Sutton ([124I]meta-Iodobenzylguanidine)

Completed
Has Results
  • Metastatic Neuroblastoma
  • London, United Kingdom
  • +1 more
May 27, 2021

MIBG Avid Tumors Trial in Columbus (MIBG)

Recruiting
  • MIBG Avid Tumors
  • Columbus, Ohio
    Nationwide Children's Hospital
May 20, 2021

Neuroendocrine Tumors Trial in Ann Arbor (3-[18F]Fluoro-para-hydroxyphenethylguanidine, [123I] metaiodobenzylguanidine, Positron

Recruiting
  • Neuroendocrine Tumors
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021

Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

Available
  • Neuroblastoma
  • Childhood Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
  • 131 I-MIBG
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 11, 2022

Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Minneapolis (131 I-Metaiodobenzylguanidine (131I-MIBG), Potassium

Recruiting
  • Relapsed Neuroblastoma
  • Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131I-MIBG)
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Jan 20, 2022

Neuroblastoma Trial in San Francisco (124I-Metaiodobenzylguanidine (MIBG) (no-carrier added), 124I-MIBG (carrier added),

Terminated
  • Neuroblastoma
  • 124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)
  • +2 more
  • San Francisco, California
    University of California, San Francisco
May 12, 2021

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT

Terminated
  • Pheochromocytoma
  • Paraganglioma
  • F-18 FDOPA PET/CT
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 13, 2023

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR

Recruiting
  • Ischemic Heart Disease
  • +5 more
  • Cardiovascular Magnetic Resonance Imaging with Exercise Bike
  • +3 more
  • Singapore, Singapore
  • +1 more
May 31, 2021

Symptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease Trial in Los Angeles (Terazosin

Recruiting
  • Symptomatic Parkinson Disease
  • +2 more
  • Terazosin therapy
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 23, 2022

REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease Trial in Los Angeles (Carvedilol)

Recruiting
  • REM Sleep Behavior Disorder
  • +2 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 23, 2022

Neuroblastoma Trial in Lund (iodine I 131 metaiodobenzylguanidine, Fludarabine, Thiotepa)

Active, not recruiting
  • Neuroblastoma
  • iodine I 131 metaiodobenzylguanidine
  • +7 more
  • Lund, Sweden
    Lund University Hospital, Department of Pediatric Oncology and B
Feb 17, 2021

Mental Stress Reactivity in Women With CMD

Recruiting
  • Post-menopause
  • Study Procedures
  • Atlanta, Georgia
  • +3 more
Dec 7, 2022

Neuroblastoma Trial in United States (DFMO)

Active, not recruiting
Has Results
  • Neuroblastoma
  • Phoenix, Arizona
  • +21 more
Jan 25, 2023

Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))

Recruiting
  • Neuroendocrine Tumors
  • Liver Metastases
  • TheraSpheres Selective Internal Radiation Therapy (SIRT)
  • London, United Kingdom
    Imperial College NHS Trust
Mar 8, 2022

Patients With Previously Diagnosed High-Risk Neuroblastoma

Active, not recruiting
  • Recurrent Neuroblastoma
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Birmingham, Alabama
  • +97 more
Oct 28, 2022